
πππ₯π©π‘ ππ¨π‘ππ² ππ πππ
@rmohty
@KUInternalMed @sonostache @StanfordNeph @glomcon @StanfordCCM
ID: 786719374459547648
14-10-2016 00:04:50
2,2K Tweet
603 Followers
649 Following







Neghae Mawla, MD Asdin American Society of Nephrology Prabir Roy Chaudhury Bharat Sachdeva MD Robert Shahverdyan, MD Theodore Saad Rick Mishler Brian Rifkin, MD No data. Donβt hold and proceed with angiogram/PTA. The writer of this question may not realize that some interventionalists give heparin during these procedures without ill effect, so why hold eliquis?


Brad Spellberg Juan Pablo SΓ‘nchez Navarro For those viewers not in the know academic.oup.com/cid/article/66β¦




π¨π¨π¨Check out this KI Reports Community blog by β¦Medhavi Gautamβ© #NephTwitter Battle of the Filters: Immunoadsorption and Plasma Exchange Go Head-to-Head in Autoantibody Clearance - the CINEVAS TRIAL kireportscommunity.org/post/battle-ofβ¦

Gem of a @CJASN case series Reserach Letter from our colleagues Stanford Pathology πππ₯π©π‘ ππ¨π‘ππ² ππ πππ Vasculitis skin findings not uncommon in IRGN (12%), ANCA+ 25% - mainly MPO Only 11/24 biopsies had EM but of these only 5/11 with subepithelial humps journals.lww.com/cjasn/citationβ¦



Now open access in NDT fernando fervenza Fernando Caravaca-FontΓ‘n Hydroxychloroquine for all patients with lupus nephritis: No! π§"In an era of modern immunosuppression ... HCQ for all no longer makes sense" "Yes" part will come in NDT soon βΆοΈacademic.oup.com/ndt/article/doβ¦

Time for a new look at how to manage LN. The old proteinuric centric approach is not enough. In patients with anti-ds-DNA and proliferative LN, targeting immunological remission (negative anti-ds-DNA and normalization of complement) is the key π! kidney-international.org/article/S0085-β¦

Prashanth Francis, MD PhD Yuval Patel There is a concern of βhemodynamic instabilityβ with LVP that I do not understand but has to do with people not fully grasping how ascites is formed.

Graham Abra, MD The whole phosphate binder industry complex and this drug needs to continue to have massive scrutiny. Never has so much π° been wasted chasing something without any solid evidence of benefit. If they would invested in the research before the guidelines we could have clarity